Written Question·Department of Health and Social Care·UIN 39223

Cushing's Syndrome: Tirzepatide

Tabled: 18 March 2025
Answered: 26 March 2025

Question

Charlotte Cane

Liberal DemocratEly and East Cambridgeshire

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of prescribing Mounjaro for Cushing's syndrome on the NHS.

Answer

Karin Smyth
The Department has made no assessment. Mounjaro is not licensed as a treatment option for Cushing’s syndrome. The National Institute for Health and Care Excellence (NICE) would consider an evaluation of Mounjaro for Cushing’s syndrome if the company, Eli ...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 39223) →

Partner sites